You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage IVB follicular thyroid cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Columnar Cell Variant Thyroid Gland Papillary Carcinoma, Follicular Variant Thyroid Gland Papillary Carcinoma, Metastatic

Active, not recruiting
  • Columnar Cell Variant Thyroid Gland Papillary Carcinoma
  • +25 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Torrance, California
  • +6 more
Jan 12, 2023

Pathological Manifestation in Thyroid Follicular Neoplasm: Early

Not yet recruiting
  • Thyroid Cancer
  • Follicular Thyroid Cancer
    • (no location specified)
    Jul 20, 2022

    Studies on Tumors of the Thyroid

    Recruiting
    • Hurthle Cell Thyroid Cancer
    • +4 more
    • 68-Gallium Dotatate
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Thyroglobulin and Galectin-3 for Prognosis and Follow-up in

    Recruiting
    • Thyroid Cancer
    • +2 more
      • Taipei, Taiwan
        Chih-Yuan Wang, M.D
      Oct 16, 2022

      Thyroid Cancer, Thyroid Cancer, Follicular, Papillary Thyroid Cancer Trial in United States (Trametinib, Dabrafenib, PDR001)

      Recruiting
      • Thyroid Cancer
      • +6 more
      • Basking Ridge, New Jersey
      • +6 more
      Jan 19, 2023

      Thyroid Cancer, Thyroid Carcinoma, Metastatic Thyroid Cancer Trial in Boston (Selpercatinib, Sodium Iodine I-131, rhTSH)

      Not yet recruiting
      • Thyroid Cancer
      • +5 more
      • Boston, Massachusetts
        Massachusetts General Hospital
      Dec 20, 2022

      Surgical Management of Advanced Thyroid Cancer

      Recruiting
      • Thyroid Carcinoma
      • +6 more
      • Thyroidectomy with or without lymphadenectomy or multivisceral resection
      • Rome, Italy
        Fondazione Policlinico Universitario Agostino Gemelli IRCCS
      Mar 31, 2023

      18F-TFB PET/CT Scan in Differentiated Thyroid Cancer

      Recruiting
      • Differentiated Thyroid Gland Carcinoma
      • +2 more
      • Computed Tomography
      • +3 more
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Jan 4, 2023

      BRAF NP_004324.2:p.V600M, BRAF V600E Mutation Present, Metastatic Thyroid Gland Carcinoma Trial in Portland (Binimetinib,

      Recruiting
      • BRAF NP_004324.2:p.V600M
      • +6 more
      • Portland, Oregon
        Providence Portland Medical Center
      Aug 17, 2022

      Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma, Ann

      Active, not recruiting
      • Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma
      • +11 more
      • Washington, District of Columbia
      • +6 more
      Feb 2, 2023

      Active, not recruiting
      • Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
      • +8 more
      • Cetuximab
      • +3 more
      • Pittsburgh, Pennsylvania
        University of Pittsburgh Cancer Institute (UPCI)
      Jan 26, 2023

      Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage III Follicular Lymphoma, Ann Arbor Stage IV Follicular Lymphoma Trial in

      Recruiting
      • Ann Arbor Stage II Follicular Lymphoma
      • +5 more
      • Fresno, California
      • +2 more
      Jan 24, 2023

      Refractory Thyroid Gland Carcinoma, Refractory Thyroid Gland Papillary Carcinoma, Refractory Thyroid Gland Follicular Carcinoma

      Recruiting
      • Refractory Thyroid Gland Carcinoma
      • +3 more
      • 177Lu-DOTA-EB-FAPI 1 radionuclide therapy
      • +2 more
      • Xiamen, China
        The First Affiliated Hospital of Xiamen University
      Nov 3, 2022

      Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2 Follicular Lymphoma, Ann Arbor Stage II Grade 1

      Active, not recruiting
      • Ann Arbor Stage I Grade 1 Follicular Lymphoma
      • +3 more
      • Clinical Observation
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 5, 2022

      Thyroid Cancer Trial in Suita (Targeted alpha therapy)

      Recruiting
      • Thyroid Cancer
      • Targeted alpha therapy
      • Suita, Japan
        Osaka University Hospital
      Mar 2, 2022

      Esophageal Tumor Metastatic, Esophageal Cancer Stage IVb Trial in Beijing (drug, biological, radiation)

      Recruiting
      • Esophageal Neoplasm Metastatic
      • Esophageal Cancer Stage IVb
      • TP (Paclitaxel with cisplatin or carboplatin) or PF (Fluoropyrimidine with cisplatin or carboplatin) regimen depended on investigator's choice.
      • +3 more
      • Beijing, Beijing, China
        Cancer hospital, CAMS
      Oct 19, 2023

      Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in

      Recruiting
      • Advanced Differentiated Thyroid Gland Carcinoma
      • +102 more
      • Cabozantinib S-malate
      • Nivolumab
      • Chicago, Illinois
      • +2 more
      Apr 5, 2022

      Benign Thyroid Gland Tumor, Recurrent Thyroid Gland Carcinoma, Thyroid Gland Follicular Tumor of Uncertain Malignant Potential

      Recruiting
      • Benign Thyroid Gland Neoplasm
      • +4 more
      • Quality-of-Life Assessment
      • Radiofrequency Ablation
      • Houston, Texas
        M D Anderson Cancer Center
      Sep 3, 2022

      Thyroid Tumor Follicular, Bone Metastases Trial in Beijing (Sr-89)

      Not yet recruiting
      • Thyroid Neoplasm Follicular
      • Bone Metastases
      • Beijing, China
        Peking Union Medical College Hospital
      Jul 18, 2022

      Head and Neck Carcinoma of Unknown Primary, Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced

      Recruiting
      • Head and Neck Carcinoma of Unknown Primary
      • +24 more
      • New Brunswick, New Jersey
        Rutgers Cancer Institute of New Jersey
      Aug 6, 2022

      Cardiovascular Disorder, Chronic Kidney Disease, Metastatic Renal Cell Carcinoma Trial in United States (Best Practice, Blood

      Recruiting
      • Cardiovascular Disorder
      • +8 more
      • Best Practice
      • +4 more
      • Creve Coeur, Missouri
      • +24 more
      Aug 10, 2022

      Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma

      Terminated
      • Metastatic Colon Adenocarcinoma
      • +27 more
      • San Francisco, California
      • +1 more
      Jan 5, 2023

      Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2

      Active, not recruiting
      • Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma
      • +22 more
      • External Beam Radiation Therapy
      • Orbital Radiation
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 9, 2022

      Aberrant Helix Pomatia Agglutinin Binding Glycan Expression in

      Completed
      • Follicular Thyroid Cancer
      • Lectin-histochemistry retrospectively performed
      • Singapore, Singapore
        National University Hospital
      Sep 25, 2021

      Metastatic Esophageal Squamous Cell Carcinoma Trial in Guangzhou (Intensity-modulated radiotherapy concurrent with capecitabine)

      Recruiting
      • Metastatic Esophageal Squamous Cell Carcinoma
      • Intensity-modulated radiotherapy concurrent with capecitabine
      • Guangzhou, Guangdong, China
        Sun yat-sen University Cancer center
      Aug 21, 2022